NO20003313L - Terapeutiske midler - Google Patents

Terapeutiske midler

Info

Publication number
NO20003313L
NO20003313L NO20003313A NO20003313A NO20003313L NO 20003313 L NO20003313 L NO 20003313L NO 20003313 A NO20003313 A NO 20003313A NO 20003313 A NO20003313 A NO 20003313A NO 20003313 L NO20003313 L NO 20003313L
Authority
NO
Norway
Prior art keywords
compound
formula
therapeutic agents
human
treatment
Prior art date
Application number
NO20003313A
Other languages
English (en)
Other versions
NO20003313D0 (no
Inventor
David John Heal
Helen Cristine Jackson
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of NO20003313D0 publication Critical patent/NO20003313D0/no
Publication of NO20003313L publication Critical patent/NO20003313L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
NO20003313A 1997-12-24 2000-06-23 Terapeutiske midler NO20003313L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9727131.6A GB9727131D0 (en) 1997-12-24 1997-12-24 Therapeutic agents
PCT/EP1998/008249 WO1999033450A2 (en) 1997-12-24 1998-12-16 Pharmaceutical composition containing sibutramine and orlistat

Publications (2)

Publication Number Publication Date
NO20003313D0 NO20003313D0 (no) 2000-06-23
NO20003313L true NO20003313L (no) 2000-08-11

Family

ID=10824083

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003313A NO20003313L (no) 1997-12-24 2000-06-23 Terapeutiske midler

Country Status (26)

Country Link
US (1) US6403641B2 (no)
EP (1) EP1039900B1 (no)
JP (1) JP2001527036A (no)
KR (1) KR20010033531A (no)
CN (1) CN1134257C (no)
AT (1) ATE268174T1 (no)
AU (1) AU758181B2 (no)
BG (1) BG104568A (no)
BR (1) BR9814498A (no)
CA (1) CA2315259A1 (no)
CZ (1) CZ20002392A3 (no)
DE (1) DE69824313T2 (no)
DK (1) DK1039900T3 (no)
ES (1) ES2222001T3 (no)
GB (1) GB9727131D0 (no)
HK (1) HK1034446A1 (no)
HU (1) HUP0300615A3 (no)
IL (1) IL136733A (no)
NO (1) NO20003313L (no)
NZ (1) NZ505686A (no)
PL (1) PL342099A1 (no)
PT (1) PT1039900E (no)
SK (1) SK9492000A3 (no)
TR (1) TR200001869T2 (no)
UA (1) UA70310C2 (no)
WO (1) WO1999033450A2 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6974838B2 (en) 1998-08-24 2005-12-13 Sepracor Inc. Methods of treating or preventing pain using sibutramine metabolites
US6339106B1 (en) 1999-08-11 2002-01-15 Sepracor, Inc. Methods and compositions for the treatment and prevention of sexual dysfunction
US6331571B1 (en) 1998-08-24 2001-12-18 Sepracor, Inc. Methods of treating and preventing attention deficit disorders
US6476078B2 (en) 1999-08-11 2002-11-05 Sepracor, Inc. Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
GB9914744D0 (en) * 1999-06-24 1999-08-25 Knoll Ag Therapeutic agents
US6399826B1 (en) 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
NZ523684A (en) 2000-07-28 2005-04-29 F New pharmaceutical composition
US6610887B2 (en) 2001-04-13 2003-08-26 Sepracor Inc. Methods of preparing didesmethylsibutramine and other sibutramine derivatives
US6730319B2 (en) * 2001-06-06 2004-05-04 Hoffmann-La Roche Inc. Pharmaceutical compositions having depressed melting points
CA2530634A1 (en) * 2003-06-12 2004-12-23 Menachem Rubinstein Methods of treating obesity and related disorders using tellurium and selenium compounds
US20050131074A1 (en) * 2003-08-04 2005-06-16 Beckman Kristen M. Methods for treating metabolic syndrome
WO2005107777A1 (en) 2004-05-10 2005-11-17 Den Kgl. Veterinær- Og Landbohøjskole Flaxseeds for body weight management
EP2190303A1 (en) 2007-09-12 2010-06-02 Københavns Universitet Compositions and methods for increasing the suppression of hunger and reducing the digestibility of non-fat energy satiety
US20090214682A1 (en) * 2008-02-22 2009-08-27 Heuer Marvin A Composition and methods for weight loss in a subject
JP5738011B2 (ja) * 2011-03-04 2015-06-17 株式会社ブリヂストン 二次電池の非水電解液用添加剤、二次電池用非水電解液及び非水電解液二次電池
CN102872062A (zh) * 2011-07-13 2013-01-16 鲁南制药集团股份有限公司 一种治疗或预防肥胖症以及代谢综合症的药物组合物
JP2013147488A (ja) * 2011-12-21 2013-08-01 Taisho Pharmaceutical Co Ltd 固形製剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52768B1 (en) 1981-04-06 1988-02-17 Boots Co Ltd 1-arylcyclobutylalkylamine compounds useful as therapeutic agents
CA1247547A (en) * 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
CA1328881C (en) 1984-12-21 1994-04-26 Pierre Barbier Process for the manufacture of oxetanones
GB8531071D0 (en) 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
GB8704777D0 (en) 1987-02-28 1987-04-01 Boots Co Plc Medical treatment
JP2675573B2 (ja) 1988-03-31 1997-11-12 科研製薬株式会社 脳機能改善剤
IE61928B1 (en) 1988-11-29 1994-11-30 Boots Co Plc Treatment of obesity
TW381025B (en) 1993-08-05 2000-02-01 Hoffmann La Roche Pharmaceutical composition containing a glucosidase inhibitor and a lipase inhibitor
US5459164A (en) 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment

Also Published As

Publication number Publication date
CZ20002392A3 (cs) 2002-01-16
US6403641B2 (en) 2002-06-11
IL136733A (en) 2004-08-31
US20020010160A1 (en) 2002-01-24
CN1134257C (zh) 2004-01-14
DE69824313D1 (de) 2004-07-08
DE69824313T2 (de) 2005-08-25
HUP0300615A2 (hu) 2003-07-28
ES2222001T3 (es) 2005-01-16
PL342099A1 (en) 2001-05-21
NZ505686A (en) 2002-07-26
PT1039900E (pt) 2004-09-30
DK1039900T3 (da) 2004-10-04
CA2315259A1 (en) 1999-07-08
WO1999033450A3 (en) 1999-09-02
KR20010033531A (ko) 2001-04-25
BG104568A (bg) 2001-02-28
IL136733A0 (en) 2001-06-14
NO20003313D0 (no) 2000-06-23
TR200001869T2 (tr) 2000-10-23
JP2001527036A (ja) 2001-12-25
AU2273899A (en) 1999-07-19
CN1284872A (zh) 2001-02-21
HUP0300615A3 (en) 2005-04-28
WO1999033450A2 (en) 1999-07-08
SK9492000A3 (en) 2001-07-10
BR9814498A (pt) 2000-10-10
EP1039900B1 (en) 2004-06-02
EP1039900A2 (en) 2000-10-04
UA70310C2 (uk) 2004-10-15
ATE268174T1 (de) 2004-06-15
AU758181B2 (en) 2003-03-20
GB9727131D0 (en) 1998-02-25
HK1034446A1 (en) 2001-10-26

Similar Documents

Publication Publication Date Title
NO20003313L (no) Terapeutiske midler
CY1118651T1 (el) Αζακυκλικες ενωσεις για χρηση στην θεραπευτικη αντιμετωπιση ασθενειων που σχετιζονται με τη σεροτονινη
EG25822A (en) Quinolinyl-pyrrolopyrazoles
ES2295609T3 (es) Derivados de tiadiazolilpiperazina utiles para tratar o prevenir un dolor.
DK1346041T3 (da) Terapeutiske midler og fremgangsmåder til anvendelse deraf til behandling af en amyloidogen sygdom
DK0869808T3 (da) Anvendelse af Glu-Trp-dipeptider til fremstilling af et lægemiddel til behandling af forskellige tilstande, der involverer neovaskularisation
LU91254I2 (fr) Daptomycine et ses dérivés pharmaceutiquement acceptables (cubicinr)
DK1151009T3 (da) Antimikrobielt/endotoksin-neutraliserende polypeptid
MY119375A (en) Treatment of tinnitus using neuroprotective agents
TR200103613T2 (tr) Burun içinden tatbik edilen morfini içeren farmasötik formülasyonlar ve yöntemler.
DK0998287T3 (da) Anvendelse af levobupivacain
ES2147788T3 (es) 3,4-diarilcromanos para el tratamiento de la dermatitis.
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
MXPA01012936A (es) Composicion farmaceutica que contiene sibutramina y orlistat.
NO20031410D0 (no) Antitumorterapi innbefattende distamycinderivater
SE9902597D0 (sv) New use
BG106209A (en) Therapeutic agents
EE9800315A (et) Meetod südamepuudulikkuse käitlemiseks endoteliini antagonistide abil
PT1183046E (pt) Derivado de aminotetralina para a terapia de doencas cardiovasculares
AU4918900A (en) Interferon-beta use in the treatment of ewing's family of tumors
MD1469G2 (ro) Metodă de tratament al şocului combustional
RU99118112A (ru) Способ лечения больных с невротическими расстройствами препаратом "миелопид"

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application